Author

Joan Huaqiong Shen

OpenAlex ID: A5035870783

Lemzoparlimab, a Differentiated Anti-CD47 Antibody in Combination with Rituximab in Relapsed and Refractory Non-Hodgkin's Lymphoma: Initial Clinical Results

2021 · Amitkumar Mehta, Wael Harb, et al. · Blood · 34

385 A first-in-human study of lemzoparlimab, a differentiated anti-CD47 antibody, in subjects with relapsed/refractory malignancy: initial monotherapy results

2020 · Jordan Berlin, Wael Harb, et al. · Regular and Young Investigator Award Abstracts · 16

607 TJ210 (MOR210), a differentiated anti-C5aR antibody for anti-cancer therapy

2020 · Jane Meng, Zhengyi Wang, et al. · Regular and Young Investigator Award Abstracts

Works count: 3

Citation count: 50

H-index: 2

I10-index: 2